Navigation Links
PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Date:5/17/2012

LAKE FOREST, Ill., May 17, 2012 /PRNewswire/ -- Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and Critical Care Exposition, May 19-24, 2012 in Orlando, Florida.

(Logo: http://photos.prnewswire.com/prnh/20120517/CG09355LOGO)

Ms. Langan invites critical care professionals to visit Booth #2668 to see how the enhanced labels help clinicians and pharmacy staff with easier drug and dose recognition when stocking, retrieving, and administering compounded services from PharMEDium.  Onsite PharMEDium associates will showcase the functionality and appearance of the enhanced labels and packaging, which are resultant of PharMEDium's ongoing commitment to patient safety, quality and innovation.

"Attendees at the NTI and Critical Care Exposition anticipate seeing new ideas, approaches and innovations designed to help them provide patient safety and quality of care for critically ill patients," stated David N. Jonas, CEO and Chairman of the Board.   "As the key educational and informational event for critical care caregivers, this meeting is an ideal forum for PharMEDium to present our new and enhanced labeling for ICU services."

At the 2011 Chicago exposition, PharMEDium conducted market research with over 1000 critical care nurses, enabling PharMEDium to gain a broader understanding of the medication administration challenges critical care nurses face.  The findings were the foundation for several of the enhancements now in the market. For example, service being delivered with new labels includes Phenylephrine, Norepinephrine and Vasopressin ready-to-use compounded sterile preparations.  David N. Jonas, PharMEDium Chairman and CEO, added, "We have received positive feedback about the labeling enhancements.  We're enthusiastic to be a part of this professional group and PharMEDium is proud to be a corporate sponsor of the American Association of Critical Care Nurses."

About PharMEDium
PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium® network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit http://www.pharmedium.com.

 


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Adds O.R. Medication Verification System
2. PharMEDiums Technology Helps Hospital Pharmacists Ensure Safety
3. PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
4. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
5. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
6. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
7. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
8. PharMEDium Elects William R. Spalding to Board of Directors
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Delcath Highlights First Quarter 2012 And Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , United Kingdom and  BOSTON , March ... provider Linguamatics today announced a partnership ... . The agreement allows pharmaceutical companies to extract ... I2E text mining technology. ... 18 of the top 20 global pharmaceutical companies. ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Revolution for Truth has organized the ... parental rights and civil liberties, and to restore transparency within government agencies responsible ... with a press conference taking place Friday morning calling on President Trump to ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... Pittsburgh, PA (PRWEB) , ... March 28, 2017 ... ... built for and by physicians, announced today the launch of a free, public-facing ... The Via Cost Analyzer (VCA) was developed to provide comparative information to patients, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
Breaking Medicine News(10 mins):